PHASE I STUDY OF THE TRIPLE COMBINATION OF UFT/LEUCOVORIN, OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Marsili, Stefania [1 ]
Petrioli, Roberto [1 ]
Sabatino, Marianna [1 ]
Paolelli, Loretta [1 ]
Sciandivasci, Angela [1 ]
Pascucci, Alessandra [1 ]
Ciliberto, Domenico [1 ]
Bindi, Mirco [1 ]
Correale, Pierpaolo [1 ]
Francini, Guido [1 ]
机构：
[1] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study
    Seium, Y
    Stupp, R
    Ruhstaller, T
    Gervaz, P
    Mentha, G
    Philippe, M
    Allal, A
    Trembleau, C
    Bauer, J
    Morant, R
    Roth, AD
    ANNALS OF ONCOLOGY, 2005, 16 (05) : 762 - 766
  • [32] Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer
    Falcone, A
    Masi, G
    Allegrini, G
    Danesi, R
    Pfanner, E
    Brunetti, IM
    Di Paolo, A
    Cupini, S
    Del Tacca, M
    Conte, P
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) : 4006 - 4014
  • [33] Concurrent irinotecan, oxaliplatin, and UFT (tegafur-uracil) with leucovorin in the first-line treatment of advanced colorectal cancer: A phase I/II study
    Saunders, M.
    Sheikh, H.
    Palmer, K.
    Wilson, G.
    Sjursen, A.
    Craven, O.
    Swindell, R.
    Valle, J.
    ANNALS OF ONCOLOGY, 2007, 18 : VII86 - VII86
  • [34] Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer
    Kemeny, N
    Tong, W
    Gonen, M
    Stockman, J
    Di Lauro, C
    Teitcher, J
    White, P
    Price, C
    Saltz, L
    Sharma, S
    Graham, MA
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1490 - 1496
  • [35] Phase I study of ursodeoxycholic acid in combination with 5-fluorouracil, leucovorin, oxaliplatin, and bevacizumab for metastatic colorectal cancer
    Lai, Lily L.
    Chiu, Ken
    Lim, Dean
    Chao, Joseph
    Frankel, Paul Henry
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [36] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [37] UFT in combination with oxaliplatin:: clinical phase I study in patients with advanced or metastatic solid tumors
    Sastre, Javier
    Aranda, Enrique
    Abad, Albert
    Gallego, Javier
    Luis Manzano, Jose
    Gomez, Auxiliadora
    Carrato, Alfredo
    Lopez, Eva
    Diaz-Rubio, Eduardo
    ANTI-CANCER DRUGS, 2006, 17 (04) : 417 - 421
  • [38] A combination of oxaliplatin and UFT-I-leucovorin as first line treatment in advanced colorectal cancer.: An ONCOPAZ phase II study.
    De Castro, J
    Vicent, J
    García-Girón, C
    Constela, M
    Fonseca, E
    Montalar, J
    Lomas, M
    Antón-Aparicio, L
    Dorta, F
    González-Barón, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 300S - 300S
  • [39] Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients with metastatic colorectal cancer
    Sadahiro, S.
    Maeda, Y.
    Suzuki, T.
    Kamijo, A.
    Makuuchi, H.
    Murayama, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 188 - 189
  • [40] Irinotecan/Fluorouracil/Leucovorin or the Same Regimen Followed by Oxaliplatin/Fluorouracil/Leucovorin in Metastatic Colorectal Cancer
    Kalofonos, Haralabos P.
    Papakostas, Pavlos
    Makatsoris, Thomas
    Papamichael, Demetrios
    Vourli, Georgia
    Xanthakis, Ioannis
    Aravantinos, Gerasimos
    Papadimitriou, Christos
    Pentheroudakis, George
    Varthalitis, Ioannis
    Samelis, George
    Syrigos, Kostas N.
    Xiros, Nikolaos
    Stavropoulos, Michalis
    Kosmidis, Paris
    Christodoulou, Christos
    Linardou, Helen
    Skondra, Maria
    Pectasides, Dimitrios
    Economopoulos, Theofanis
    Fountzilas, George
    ANTICANCER RESEARCH, 2010, 30 (10) : 4325 - 4333
12345